These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 5725869)

  • 41. [Clinical experimentation with a new topical corticosteroid: fluocinonide].
    Coppolino C; Sposato N
    Arch Ital Dermatol Venereol Sessuol; 1971; 37(1):5-12. PubMed ID: 4260100
    [No Abstract]   [Full Text] [Related]  

  • 42. [2 new corticosteroids for local application].
    Thomsen K
    Ugeskr Laeger; 1974 Nov; 136(48):2696-7. PubMed ID: 4439511
    [No Abstract]   [Full Text] [Related]  

  • 43. [New corticosteroid preparation for topical use in dermatology].
    Vistoli O
    Arch Ital Dermatol Venereol Sessuol; 1971; 37(1):13-30. PubMed ID: 5147964
    [No Abstract]   [Full Text] [Related]  

  • 44. Double-blind clinical trial comparing fluocinonide FAPG cream with flumethasone pivalate cream.
    Baran R
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):79-81. PubMed ID: 5291638
    [No Abstract]   [Full Text] [Related]  

  • 45. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Topical steroids--which one?
    Wachs GN
    Int J Dermatol; 1973; 12(1):8-9. PubMed ID: 4694183
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of 0,015 per cent Triamcinolone acetonide cream and 1,0 per cent Hydrocortisone acetate cream in hemi-experiments].
    Wysocki R
    Ther Ggw; 1972 Apr; 111(4):565 passim. PubMed ID: 5029718
    [No Abstract]   [Full Text] [Related]  

  • 48. [The use of "Synalar" ointment in the treatment of patients with various dermatoses].
    Prorvich LV; Zudin BI
    Vestn Dermatol Venerol; 1966 Apr; 40(4):73-5. PubMed ID: 6011191
    [No Abstract]   [Full Text] [Related]  

  • 49. [Pilar pytiriasis rubra improved by applications of fluocinolone acetonide cream under occlusive dressing].
    Thiers H; Colomb D; Jamain C
    Lyon Med; 1966 Apr; 215(17):1181-2. PubMed ID: 4222525
    [No Abstract]   [Full Text] [Related]  

  • 50. [Binocular Fluocinolone Acetonide Intravitreal Implant for Therapy-Resistant Diabetic Maculopathy].
    Linz K; Auffarth GU; Kretz FT
    Klin Monbl Augenheilkd; 2015 Oct; 232(10):1208-12. PubMed ID: 25853942
    [No Abstract]   [Full Text] [Related]  

  • 51. [Value of 0.025 percent fluocinolone acetonide in dry dermatoses].
    Laure M; Mari
    Mars Med; 1968; 105(3):287-8. PubMed ID: 5739898
    [No Abstract]   [Full Text] [Related]  

  • 52. Photosensitivity following treatment with occlusive dressings.
    Cattano AN
    Arch Dermatol; 1970 Sep; 102(3):276-9. PubMed ID: 5456017
    [No Abstract]   [Full Text] [Related]  

  • 53. [Clinical experiments on the topical use of fluocinolone acetonide in propylene glycol].
    Vignali C
    Arcisp S Anna Ferrara; 1966; 19(4):535-40. PubMed ID: 5959876
    [No Abstract]   [Full Text] [Related]  

  • 54. Letter: Evaluation of desonide cream.
    Van Scott EJ
    JAMA; 1973 Dec; 226(13):1569. PubMed ID: 4587318
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of granuloma telangiectaticum with 0.2 per cent fluocinolone acetonide cream.
    Kandil E
    Acta Derm Venereol; 1970; 50(2):140-2. PubMed ID: 4193918
    [No Abstract]   [Full Text] [Related]  

  • 56. Fluocinonide--a new topical corticosteroid. Clinical evaluation.
    Mendelson CG
    Acta Derm Venereol Suppl (Stockh); 1971 May; 52(67):63-5. PubMed ID: 5291635
    [No Abstract]   [Full Text] [Related]  

  • 57. [Our experience with Topsyne APG, a new topical corticosteroid].
    Témime P; Privat Y; Marchand JP; Llucia P
    Therapeutique; 1971 Dec; 47(10):857-9. PubMed ID: 5145548
    [No Abstract]   [Full Text] [Related]  

  • 58. [Practical value and evaluation criteria of external corticoid drugs].
    Weirich EG
    Wien Med Wochenschr; 1966 Aug; 116(34):681-8 concl. PubMed ID: 5987614
    [No Abstract]   [Full Text] [Related]  

  • 59. [Local dermatological therapy with corticosteroids].
    Wereide K
    Tidsskr Nor Laegeforen; 1970 Sep; 90(17):1633-4. PubMed ID: 5456623
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of percutaneous absorption of fluocinolone acetonide on the activity of superoxide dismutase and total antioxidant status in patients with psoriasis.
    Gavan N; Popa R; Orasan R; Maibach H
    Skin Pharmacol; 1997; 10(4):178-82. PubMed ID: 9413891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.